Navigation Links
AVMA Responds to Federal Order Limiting Use of Antibiotics In Food Animals

SCHAUMBURG, Ill., Jan. 6, 2012 /PRNewswire-USNewswire/ -- The American Veterinary Medical Association (AVMA) announced today that the FDA's order prohibiting certain uses of cephalosporins in food animals appears consistent with the current AVMA position on the limited prohibition on extra-label drug use, but warned against further restrictions not backed by science.

Cephalosporins, a class of antimicrobial drug used in livestock, poultry and other food-producing animals, are also commonly used in humans to treat pneumonia and a wide range of skin and soft tissue infections, urinary tract infections and inflammatory disease. The FDA said it is limiting the use of cephalosporins in animals to preserve the effectiveness of the drugs for treating disease in humans and reduce the risk of cephalosporin resistance in certain bacterial pathogens.

"The AVMA is pleased that the FDA reviewed and thoughtfully considered the many comments received from stakeholders, including veterinarians, while taking action to preserve the effectiveness of cephalosporin drugs for treating disease in humans," said Dr. Rene Carlson, AVMA president. "Veterinarians are committed to improving the health and welfare of people, animals and the environment, and we hope the FDA's order will allow veterinarians to have therapeutic options for food animals while also protecting public health."

The AVMA is evaluating the prohibition of cephalosporins for preventive uses and will submit a response to the FDA during the comment period. The AVMA has a strong position which underscores the importance of veterinary access to antimicrobials for preventive use to enhance food safety, public health and animal welfare.

"We are committed to the judicious use of antimicrobials in food animals," said Dr. Carlson. "While this measure appears to be consistent with our position, we will continue to review any further restrictions to make sure they are backed by science and don't place arbitrary and ultimately harmful limits on veterinarians' ability to treat animals and ensure a safe and healthy food supply."

For more information, contact Michael San Filippo, AVMA media relations assistant, at 847-285-6687 (office), 847-732-6194 (cell), or For more information about the AVMA, visit  

The AVMA, founded in 1863, is one of the oldest and largest veterinary medical organizations in the world, with more than 81,500 member veterinarians worldwide engaged in a wide variety of professional activities. For more information, visit

SOURCE American Veterinary Medical Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ampio Responds to Recent Publications by Anonymous Short Sellers
2. Nationwide Coalition Responds to Express Scripts CEO Statement: "I Cant Stop Certain Pharmacies From Going Out of Business"
3. China Medical Technologies Responds to the Allegations Raised by Glaucus Research Group
4. International Academy of Compounding Pharmacists (IACP) Responds to FDAs Appeal of the U.S. District Court Ruling on Pharmacy Compounding
5. Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimers Patent Application
6. NeuroSigma Responds to Substantial Interest Generated by NPR Story on Promising Epilepsy Clinical Trial
7. Cellestis Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis
8. Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
9. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
10. NCPA Responds to Consumer Groups Request for CVS Caremark Divestiture
11. Mangrove Partners Responds to Erroneous CPEX Assertions
Post Your Comments:
(Date:6/24/2016)... 2016   Bay Area Lyme Foundation , ... Center for Tick Borne Illness , Harvard Medical ... Hacking Medicine, University of California, Berkeley, and the ... five finalists of Lyme Innovation , the ... 100 scientists, clinicians, researchers, entrepreneurs, and investors from ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, ... -based mobile pulmonary function testing company, is now able to perform ... developed by ndd Medical Technologies , Inc. ... in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL ... can get any needed testing done in the comfort of her ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):